Literature DB >> 6540631

Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity.

J Uozumi, M Ishizawa, Y Iwamoto, T Baba.   

Abstract

To elucidate the mechanisms of inactivation of cis-diamminedichloroplatinum(II) (DDP) toxicity by its antidote sodium thiosulfate (STS), we studied the effects of STS on plasma concentrations of platinum (Pt) in vivo, binding of Pt to serum protein in vitro, and uptake of Pt by bacterial cells (E. coli, WP 2 uvrA strain) or cultured mouse tumor cells (FM3A) in vitro. STS did not significantly affect either plasma levels of total Pt or non-protein-bound Pt in vivo, but did inhibit binding of Pt to serum protein and cellular uptake of Pt in vitro. These results suggest that when DDP is given in combination with STS in vivo, the binding to macromolecules and entry of DDP into the cells are prevented due to formation of the Pt-thiosulfate complex in the extracellular fluid.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6540631     DOI: 10.1007/bf00257119

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  21 in total

1.  Distribution of cis-platin in blood.

Authors:  R C Manaka; W Wolf
Journal:  Chem Biol Interact       Date:  1978-09       Impact factor: 5.192

2.  Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.

Authors:  T F Patton; K J Himmelstein; R Belt; S J Bannister; L A Sternson; A J Repta
Journal:  Cancer Treat Rep       Date:  1978-09

3.  Establishment of cell lines in vitro from a mammary ascites tumor of mouse and biological properties of the established lines in a serum containing medium.

Authors:  N Nakano
Journal:  Tohoku J Exp Med       Date:  1966-01-25       Impact factor: 1.848

4.  Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.

Authors:  S B Howell; R Taetle
Journal:  Cancer Treat Rep       Date:  1980 Apr-May

5.  Mutagen testing using TRP+ reversion in Escherichia coli.

Authors:  M H Green; W J Muriel
Journal:  Mutat Res       Date:  1976-02       Impact factor: 2.433

6.  Kinetics of cis-dichlorodiammineplatinum.

Authors:  P E Gormley; J M Bull; A F LeRoy; R Cysyk
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

7.  Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.

Authors:  S B Howell; C E Pfeifle; W E Wung; R A Olshen
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

Review 8.  Phase II trials with cis-dichlorodiammineplatinum(II) in the treatment of urothelial cancer.

Authors:  A Yagoda
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

Review 9.  cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.

Authors:  R C Young; D D Von Hoff; P Gormley; R Makuch; J Cassidy; D Howser; J M Bull
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

10.  "Two route chemotherapy" using cis-diamminedichloro-platinum(II) and its antidote, sodium thiosulfate, for peritoneally disseminated cancer in rats.

Authors:  S Taniguchi; T Baba
Journal:  Gan       Date:  1982-06
View more
  14 in total

Review 1.  Cisplatin nephrotoxicity. A review.

Authors:  G Daugaard; U Abildgaard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Pharmacokinetic drug interactions of commonly used anticancer drugs.

Authors:  F M Balis
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

3.  Experiences with sodium thiosulfate after intracarotid infusion of cisplatin and BCNU for malignant gliomas.

Authors:  R B Vance; J Pittisapu; J P Kapp
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

4.  Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors.

Authors:  S Aamdal; O Fodstad; A Pihl
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  "Two-route chemotherapy" using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats.

Authors:  H Kobayashi; K Hasuda; K Aoki; T Kuroiwa; S Taniguchi; T Baba
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate.

Authors:  M Markman; R D'Acquisto; N Iannotti; M Kris; T Hakes; D Bajorin; G Bosl; B Reichman; E Casper; G Magill
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 7.  Clinical management of cytotoxic drug overdose.

Authors:  L L Thomas; M J Mertens; A E von dem Borne; C J van Boxtel; C H Veenhof; E P Veies
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

8.  The effect of sodium thiosulfate on ototoxicity and pharmacokinetics after cisplatin treatment in guinea pigs.

Authors:  T Saito; Z J Zhang; Y Manabe; T Ohtsubo; H Saito
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 9.  WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.

Authors:  M Treskes; W J van der Vijgh
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  The effect of cisplatin on renal ATPase activity in vivo and in vitro.

Authors:  J Uozumi; C L Litterst
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.